Nifty
Sensex
:
:
16041.55
53746.45
-83.60 (-0.52%)
-306.16 (-0.57%)

Pharmaceuticals & Drugs - API

Rating :
40/99

BSE: 532815 | NSE: SMSPHARMA

87.00
24-May-2022
  • Open
  • High
  • Low
  • Previous Close
  •  86.00
  •  87.90
  •  83.55
  •  85.45
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  21542
  •  18.58
  •  198.80
  •  81.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 735.20
  • 9.34
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 945.21
  • 0.35%
  • 1.58

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 67.29%
  • 2.82%
  • 26.38%
  • FII
  • DII
  • Others
  • 0.61%
  • 0.00%
  • 2.90%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.00
  • 4.80
  • 6.60

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.41
  • 10.02
  • 6.09

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 48.87
  • 11.35
  • 13.72

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.89
  • 17.13
  • 12.37

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.25
  • 2.08
  • 2.05

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.29
  • 8.39
  • 8.61

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Net Sales
121.25
148.87
-18.55%
174.70
130.13
34.25%
163.00
112.90
44.38%
171.29
96.47
77.56%
Expenses
94.21
114.40
-17.65%
127.91
106.46
20.15%
118.56
91.45
29.64%
130.19
82.05
58.67%
EBITDA
27.05
34.47
-21.53%
46.80
23.67
97.72%
44.44
21.44
107.28%
41.09
14.42
184.95%
EBIDTM
22.30%
23.16%
26.79%
18.19%
27.26%
18.99%
23.99%
14.95%
Other Income
2.13
0.86
147.67%
1.36
0.92
47.83%
1.29
0.81
59.26%
1.30
3.09
-57.93%
Interest
4.75
2.94
61.56%
4.82
2.72
77.21%
4.96
2.95
68.14%
2.55
2.87
-11.15%
Depreciation
8.10
5.63
43.87%
8.09
5.61
44.21%
8.00
5.49
45.72%
5.54
6.00
-7.67%
PBT
16.33
26.75
-38.95%
35.24
16.25
116.86%
32.77
13.81
137.29%
34.31
8.63
297.57%
Tax
6.05
8.43
-28.23%
10.23
5.03
103.38%
9.57
4.61
107.59%
12.10
2.38
408.40%
PAT
10.27
18.32
-43.94%
25.01
11.23
122.71%
23.20
9.20
152.17%
22.21
6.25
255.36%
PATM
8.47%
12.31%
14.32%
8.63%
14.23%
8.15%
12.97%
6.48%
EPS
1.06
2.53
-58.10%
2.72
1.30
109.23%
2.78
0.83
234.94%
2.73
0.76
259.21%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Net Sales
630.24
563.18
411.95
464.91
464.93
445.49
611.53
199.84
Net Sales Growth
29.05%
36.71%
-11.39%
0.00%
4.36%
-27.15%
206.01%
 
Cost Of Goods Sold
337.71
340.00
246.36
292.71
289.90
295.85
385.15
109.95
Gross Profit
292.53
223.18
165.59
172.20
175.03
149.64
226.38
89.88
GP Margin
46.41%
39.63%
40.20%
37.04%
37.65%
33.59%
37.02%
44.98%
Total Expenditure
470.87
442.04
331.92
374.77
371.59
370.35
522.32
150.38
Power & Fuel Cost
-
23.31
18.99
21.75
22.57
18.23
33.81
8.95
% Of Sales
-
4.14%
4.61%
4.68%
4.85%
4.09%
5.53%
4.48%
Employee Cost
-
41.17
39.35
35.59
32.80
26.92
38.11
5.81
% Of Sales
-
7.31%
9.55%
7.66%
7.05%
6.04%
6.23%
2.91%
Manufacturing Exp.
-
16.28
14.89
13.29
12.14
10.35
37.94
7.31
% Of Sales
-
2.89%
3.61%
2.86%
2.61%
2.32%
6.20%
3.66%
General & Admin Exp.
-
14.93
8.05
8.69
8.45
9.00
10.51
3.36
% Of Sales
-
2.65%
1.95%
1.87%
1.82%
2.02%
1.72%
1.68%
Selling & Distn. Exp.
-
5.09
3.70
2.25
4.81
9.67
15.99
10.41
% Of Sales
-
0.90%
0.90%
0.48%
1.03%
2.17%
2.61%
5.21%
Miscellaneous Exp.
-
1.25
0.58
0.49
0.91
0.33
0.80
4.59
% Of Sales
-
0.22%
0.14%
0.11%
0.20%
0.07%
0.13%
2.30%
EBITDA
159.38
121.14
80.03
90.14
93.34
75.14
89.21
49.46
EBITDA Margin
25.29%
21.51%
19.43%
19.39%
20.08%
16.87%
14.59%
24.75%
Other Income
6.08
3.45
5.11
3.40
2.39
1.45
3.61
3.03
Interest
17.08
11.19
12.32
11.92
15.48
15.82
17.11
8.23
Depreciation
29.73
22.28
22.07
19.27
19.90
19.18
19.43
4.58
PBT
118.65
91.12
50.76
62.35
60.35
41.58
56.27
39.67
Tax
37.95
30.16
18.07
20.90
19.89
5.97
14.63
14.20
Tax Rate
31.98%
33.10%
35.60%
33.52%
32.96%
14.36%
26.00%
35.80%
PAT
80.69
60.96
32.69
41.45
40.45
35.61
41.64
25.47
PAT before Minority Interest
80.69
60.96
32.69
41.45
40.45
35.61
41.64
25.47
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
12.80%
10.82%
7.94%
8.92%
8.70%
7.99%
6.81%
12.75%
PAT Growth
79.31%
86.48%
-21.13%
2.47%
13.59%
-14.48%
63.49%
 
EPS
9.53
7.20
3.86
4.89
4.78
4.20
4.92
3.01

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Shareholder's Funds
410.53
348.24
321.92
284.49
254.74
293.60
192.08
Share Capital
8.47
8.47
8.47
8.47
8.47
8.47
10.00
Total Reserves
402.06
339.77
313.45
276.02
246.28
285.14
182.07
Non-Current Liabilities
207.59
114.47
94.35
96.58
91.41
161.56
88.21
Secured Loans
146.64
67.02
61.01
70.20
73.02
109.58
65.92
Unsecured Loans
1.20
1.20
1.20
1.20
1.20
3.64
6.95
Long Term Provisions
1.84
1.73
1.52
2.18
1.35
3.43
0.00
Current Liabilities
210.09
154.21
156.05
134.29
156.00
200.43
49.03
Trade Payables
65.44
44.49
47.70
39.27
66.75
84.40
23.86
Other Current Liabilities
56.97
38.84
23.32
22.91
19.95
40.37
0.33
Short Term Borrowings
70.86
61.16
70.81
58.40
59.76
72.75
0.00
Short Term Provisions
16.82
9.72
14.22
13.71
9.54
2.90
24.84
Total Liabilities
828.21
616.92
572.32
515.36
502.15
655.59
329.32
Net Block
457.36
280.49
281.26
279.26
290.45
370.35
68.84
Gross Block
558.80
360.77
339.57
318.34
309.63
500.81
96.16
Accumulated Depreciation
101.44
80.29
58.31
39.08
19.18
130.46
27.32
Non Current Assets
502.88
389.13
351.22
334.04
335.80
408.04
83.85
Capital Work in Progress
6.74
42.12
18.30
8.20
7.76
12.80
15.02
Non Current Investment
27.30
25.81
26.99
28.38
29.10
20.51
0.00
Long Term Loans & Adv.
9.10
38.47
22.55
16.19
6.58
4.37
0.00
Other Non Current Assets
2.38
2.25
2.13
2.01
1.90
0.00
0.00
Current Assets
325.33
227.78
221.09
181.32
166.36
247.55
233.89
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.03
Inventories
137.79
129.20
136.40
107.48
92.52
112.68
49.57
Sundry Debtors
105.68
48.77
26.02
24.15
21.32
61.09
59.98
Cash & Bank
40.51
9.65
14.88
12.71
12.37
15.08
95.71
Other Current Assets
41.35
20.96
26.73
22.09
40.15
58.70
28.60
Short Term Loans & Adv.
22.17
19.20
17.06
14.89
11.67
23.49
26.79
Net Current Assets
115.24
73.57
65.04
47.03
10.36
47.13
184.86
Total Assets
828.21
616.91
572.31
515.36
502.16
655.59
329.31

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Cash From Operating Activity
90.45
39.71
49.76
31.81
73.47
61.22
14.33
PBT
91.12
50.76
62.35
60.35
41.58
56.27
39.67
Adjustment
27.76
28.66
26.81
31.08
31.58
28.14
18.09
Changes in Working Capital
-12.38
-27.60
-26.02
-48.48
9.40
-1.17
-29.61
Cash after chg. in Working capital
106.50
51.82
63.14
42.95
82.56
83.24
28.16
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-16.05
-12.10
-13.38
-11.14
-9.09
-22.02
-5.60
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-151.59
-42.56
-34.67
-16.58
-38.96
-96.72
-31.70
Net Fixed Assets
-162.65
-45.02
-31.33
-9.15
128.49
-346.44
Net Investments
0.00
0.00
0.00
-8.02
-15.71
-17.94
Others
11.06
2.46
-3.34
0.59
-151.74
267.66
Cash from Financing Activity
92.02
-2.40
-12.92
-14.89
-33.19
44.34
106.55
Net Cash Inflow / Outflow
30.88
-5.25
2.17
0.35
1.32
8.84
89.18
Opening Cash & Equivalents
9.54
14.80
12.63
12.29
11.25
2.41
6.53
Closing Cash & Equivalent
40.42
9.54
14.80
12.63
12.29
11.25
95.71

Financial Ratios

Standalone /

Consolidated
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Book Value (Rs.)
48.50
41.14
38.03
33.61
30.09
34.68
18.05
ROA
8.44%
5.50%
7.62%
7.95%
6.15%
8.46%
7.73%
ROE
16.07%
9.76%
13.67%
15.00%
12.99%
17.57%
14.11%
ROCE
17.62%
13.06%
16.57%
18.17%
12.73%
19.54%
18.91%
Fixed Asset Turnover
1.32
1.29
1.53
1.59
1.12
2.11
2.24
Receivable days
46.40
30.27
18.23
16.66
33.12
35.09
101.66
Inventory Days
80.21
107.49
88.61
73.28
82.47
47.02
84.02
Payable days
59.01
46.62
40.24
46.81
71.90
36.96
57.46
Cash Conversion Cycle
67.61
91.14
66.60
43.12
43.69
45.14
128.22
Total Debt/Equity
0.61
0.44
0.45
0.51
0.59
0.70
0.40
Interest Cover
9.14
5.12
6.23
4.90
3.63
4.29
5.82

News Update:


  • SMS Pharmaceuticals gets non-exclusive licence to manufacture, supply of nirmatrelvir
    21st Mar 2022, 15:58 PM

    The company has received licence through the Medicine Patent Pool

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.